Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101905405 | 10190540 | 5 | F | 2016 | 20160909 | 20140523 | 20160912 | EXP | CA-ROCHE-1405618 | ROCHE | 0.00 | M | Y | 0.00000 | 20160912 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101905405 | 10190540 | 1 | PS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | PREVIOUS DOSE OF RITUXIMAB: 11/DEC/2013?LAST RITUXIMAB INFUSION: 19-FEB-2015?LAST RITUXAN INFUSION: | 103705 | 1000 | MG | SOLUTION FOR INFUSION | |||||||
| 101905405 | 10190540 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | 125276 | |||||||||||
| 101905405 | 10190540 | 3 | C | DIPHENHYDRAMINE HYDROCHLORIDE. | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | |||||||||
| 101905405 | 10190540 | 4 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 1000 | MG | |||||||||
| 101905405 | 10190540 | 5 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 101905405 | 10190540 | 6 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | 0 | ||||||||||||
| 101905405 | 10190540 | 7 | C | NAPROXEN. | NAPROXEN | 1 | Unknown | AS REQUIRED | 0 | ||||||||||
| 101905405 | 10190540 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 101905405 | 10190540 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101905405 | 10190540 | 1 | Rheumatoid arthritis |
| 101905405 | 10190540 | 2 | Product used for unknown indication |
| 101905405 | 10190540 | 3 | Premedication |
| 101905405 | 10190540 | 4 | Premedication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101905405 | 10190540 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101905405 | 10190540 | Blood glucose increased | |
| 101905405 | 10190540 | Hepatic cancer | |
| 101905405 | 10190540 | Nausea | |
| 101905405 | 10190540 | Pain | |
| 101905405 | 10190540 | Rheumatoid arthritis | |
| 101905405 | 10190540 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101905405 | 10190540 | 1 | 20130430 | 0 |